.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Fish and Richardson
US Department of Justice
Merck
Baxter
Johnson and Johnson
Accenture
Express Scripts
Argus Health
Medtronic

Generated: June 28, 2017

DrugPatentWatch Database Preview

Iohexol - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for iohexol and what is the scope of iohexol freedom to operate?

Iohexol
is the generic ingredient in eight branded drugs marketed by Ge Healthcare and Interpharma Praha As, and is included in three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for iohexol. Three suppliers are listed for this compound.

Summary for Generic Name: iohexol

Tradenames:8
Patents:1
Applicants:2
NDAs:3
Drug Master File Entries: see list3
Suppliers / Packagers: see list3
Bulk Api Vendors: see list47
Clinical Trials: see list35
Patent Applications: see list2,058
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:iohexol at DailyMed

Pharmacology for Ingredient: iohexol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare
OMNIPAQUE 240
iohexol
SOLUTION;INJECTION, ORAL, RECTAL018956-002Dec 26, 1985RXYesYes► Subscribe► Subscribe
Ge Healthcare
OMNIPAQUE 300
iohexol
SOLUTION;INJECTION, ORAL, RECTAL020608-002Oct 24, 1995RXNoNo► Subscribe► Subscribe
Ge Healthcare
OMNIPAQUE 140
iohexol
INJECTABLE;INJECTION018956-005Nov 30, 1988RXYesYes► Subscribe► Subscribe
Ge Healthcare
OMNIPAQUE 240
iohexol
SOLUTION;INJECTION, ORAL, RECTAL020608-001Oct 24, 1995RXNoNo► Subscribe► Subscribe
Ge Healthcare
OMNIPAQUE 180
iohexol
SOLUTION;INJECTION, ORAL, RECTAL018956-001Dec 26, 1985RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: iohexol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge Healthcare
OMNIPAQUE 300
iohexol
SOLUTION;INJECTION, ORAL, RECTAL018956-003Dec 26, 19854,250,113► Subscribe
Ge Healthcare
OMNIPAQUE 300
iohexol
SOLUTION;INJECTION, ORAL, RECTAL018956-003Dec 26, 19854,396,597► Subscribe
Ge Healthcare
OMNIPAQUE 350
iohexol
SOLUTION;INJECTION, ORAL018956-004Dec 26, 19854,021,481► Subscribe
Ge Healthcare
OMNIPAQUE 240
iohexol
SOLUTION;INJECTION, ORAL, RECTAL018956-002Dec 26, 19854,250,113► Subscribe
Ge Healthcare
OMNIPAQUE 350
iohexol
SOLUTION;INJECTION, ORAL018956-004Dec 26, 19854,396,597► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Federal Trade Commission
Moodys
Chubb
US Department of Justice
Julphar
Farmers Insurance
Dow
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot